{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:37:28Z","timestamp":1763764648335,"version":"3.45.0"},"reference-count":53,"publisher":"Elsevier","isbn-type":[{"value":"9780443289422","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/b978-0-443-28942-2.00006-5","type":"book-chapter","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:32:33Z","timestamp":1763764353000},"page":"79-97","source":"Crossref","is-referenced-by-count":0,"title":["Nanotechnology for the therapeutic use of biologics to treat metabolic disorders"],"prefix":"10.1016","author":[{"given":"Michael","family":"Gonz\u00e1lez-Durruthy","sequence":"first","affiliation":[]},{"given":"Ana S.","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Soumya","family":"Mitra","sequence":"additional","affiliation":[]},{"given":"M. Nat\u00e1lia D.S.","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Amit Kumar","family":"Halder","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/B978-0-443-28942-2.00006-5_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3906\/sag-1912-209","article-title":"Nanotoxicity: A challenge for future medicine","volume":"50","author":"Ak\u00e7an","year":"2020","journal-title":"Turkish Journal of Medical Sciences"},{"issue":"09","key":"10.1016\/B978-0-443-28942-2.00006-5_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1055\/a-2277-4805","article-title":"Bioprotective role of phytocompounds against the pathogenesis of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis: Unravelling underlying molecular mechanisms","volume":"90","year":"2024","journal-title":"Planta Medica"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib3","series-title":"Herbal medicines for the treatment of liver cirrhosis","first-page":"185","author":"Banerjee","year":"2023"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5578\/tt.3557","article-title":"Nanoparticle: A nightmare for the future","volume":"60","author":"Berk","year":"2012","journal-title":"Tuberkuloz ve Toraks"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib5","unstructured":"Bezem, M. T. (2022). Functionalization of nanoparticles with tyrosine hydroxylase: Biotechnological and therapeutic implications (Dissertation). https:\/\/bora.uib.no\/bora-xmlui\/handle\/11250\/3018371?show=full."},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib53","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/acs.molpharmaceut.0c00960","article-title":"Relevance of electrostatics for the interaction of tyrosine hydroxylase with porous silicon nanoparticles","volume":"18","author":"Bezem","year":"2021","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphys.2017.00460","article-title":"Mitochondrial VDAC1: A key gatekeeper as potential therapeutic target","volume":"8","author":"Camara","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg","volume":"40","author":"Ciechanover","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib8","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/hmg\/ddg328","article-title":"RING finger 1 mutations in Parkin produce altered localization of the protein","volume":"12","author":"Cookson","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib9","unstructured":"Dutta, K. (2012). Engineering stimuli-responsive polymeric nanoassemblies: Rational designs for intracellular delivery of biologics. Doctoral dissertations. https:\/\/doi.org\/10.7275\/18834742."},{"issue":"1","key":"10.1016\/B978-0-443-28942-2.00006-5_bib10","first-page":"9","article-title":"Nanoparticle-labeled stem cells: A novel therapeutic vehicle","volume":"2","author":"El-Sadik","year":"2010","journal-title":"Clinical Pharmacology: Advances and Applications"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib9051","unstructured":"Esteves, A.S.C.A.D. (2011). Technology market transfer plan launch of DELIVES to E.U. Market\u00a9 (Dissertation). Universidade Nova de Lisboa. https:\/\/run.unl.pt\/bitstream\/10362\/6114\/1\/Esteves_2011.pd."},{"issue":"49","key":"10.1016\/B978-0-443-28942-2.00006-5_bib11","doi-asserted-by":"crossref","first-page":"33982","DOI":"10.1074\/jbc.M109.020115","article-title":"Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex","volume":"284","author":"Giorgio","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/B978-0-443-28942-2.00006-5_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/acs.jcim.6b00458","article-title":"Experimental-computational study of carbon nanotube effects on mitochondrial respiration: In silico nano-QSPR machine learning models based on new raman spectra transform with Markov-Shannon entropy invariants","volume":"57","author":"Gonz\u00e1lez-Durruthy","year":"2017","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.carbon.2017.01.002","article-title":"QSPR\/QSAR-based Perturbation Theory approach and mechanistic electrochemical assays on carbon nanotubes with optimal properties against mitochondrial Fenton reaction experimentally induced by Fe2+-overload","volume":"115","author":"Gonz\u00e1lez-Durruthy","year":"2017","journal-title":"Carbon"},{"issue":"3","key":"10.1016\/B978-0-443-28942-2.00006-5_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology10030171","article-title":"New mechanistic insights on carbon nanotubes\u2019 nanotoxicity using isolated submitochondrial particles, molecular docking, and nano-QSTR approaches","volume":"10","author":"Gonz\u00e1lez-Durruthy","year":"2021","journal-title":"Biology"},{"issue":"125","key":"10.1016\/B978-0-443-28942-2.00006-5_bib15","doi-asserted-by":"crossref","first-page":"103229","DOI":"10.1039\/C5RA14435C","article-title":"Mitoprotective activity of oxidized carbon nanotubes against mitochondrial swelling induced in multiple experimental conditions and predictions with new expected-value perturbation theory","volume":"5","author":"Gonz\u00e1lez-Durruthy","year":"2015","journal-title":"RSC Advances"},{"issue":"3","key":"10.1016\/B978-0-443-28942-2.00006-5_bib16","first-page":"296","article-title":"Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes\u2014MELAS syndrome","volume":"17","author":"Henry","year":"2017","journal-title":"Ochsner Journal"},{"issue":"52","key":"10.1016\/B978-0-443-28942-2.00006-5_bib17","doi-asserted-by":"crossref","first-page":"42960","DOI":"10.1074\/jbc.M505843200","article-title":"Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia","volume":"280","author":"Hetz","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1100\/tsw.2011.44","article-title":"Aggravating impact of nanoparticles on immune-mediated pulmonary inflammation","volume":"11","author":"Inoue","year":"2011","journal-title":"The Scientific World Journal"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cophys.2018.03.005","article-title":"BH3-dependent and independent activation of BAX and BAK in mitochondrial apoptosis","volume":"3","author":"Jeng","year":"2018","journal-title":"Current Opinion in Physiology"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib20","first-page":"1","article-title":"Mitochondria-targeted antioxidants: A step towards disease treatment","volume":"2020","author":"Jiang","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib21","doi-asserted-by":"crossref","first-page":"108698","DOI":"10.1016\/j.abb.2020.108698","article-title":"Mitochondrial dysfunction in the development and progression of neurodegenerative diseases","volume":"702","author":"Johnson","year":"2021","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"3","key":"10.1016\/B978-0-443-28942-2.00006-5_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40005-020-00481-0","article-title":"Mitochondrial targeted strategies and their application for cancer and other diseases treatment","volume":"50","author":"Li","year":"2020","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"6","key":"10.1016\/B978-0-443-28942-2.00006-5_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/acscentsci.2c00629","article-title":"Searching for better biomarkers for metabolic syndrome","volume":"8","author":"Madhusoodanan","year":"2022","journal-title":"ACS Central Science"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib24","series-title":"Responsive nanostructured materials for bioanalyte detection and triggered antimicrobial therapy","author":"Merkl","year":"2022"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib25","doi-asserted-by":"crossref","first-page":"102422","DOI":"10.1016\/j.nano.2021.102422","article-title":"Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines","volume":"37","author":"Milane","year":"2021","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"33","key":"10.1016\/B978-0-443-28942-2.00006-5_bib26","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.2174\/092986709789712871","article-title":"Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection","volume":"16","author":"Morin","year":"2009","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1016\/B978-0-443-28942-2.00006-5_bib27","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3109\/17435390.2012.711863","article-title":"Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors","volume":"7","author":"Nowack","year":"2012","journal-title":"Nanotoxicology"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2014.01.021","article-title":"JM-20, a novel benzodiazepine\u2013dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro","volume":"726","author":"Nu\u00f1ez-Figueredo","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib29","doi-asserted-by":"crossref","first-page":"136258","DOI":"10.1016\/j.molstruc.2023.136258","article-title":"Structural and molecular insights of protein tyrosine phosphatase 1B (PTP1B) and its inhibitors as anti-diabetic agents","volume":"1293","author":"Paul","year":"2023","journal-title":"Journal of Molecular Structure"},{"issue":"7","key":"10.1016\/B978-0-443-28942-2.00006-5_bib30","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1523\/JNEUROSCI.23-07-02735.2003","article-title":"Inhibition of bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol","volume":"23","author":"Polster","year":"2003","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/B978-0-443-28942-2.00006-5_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1179\/1351000211Y.0000000001","article-title":"Characterization of the stimulus for reactive oxygen species generation in calcium-overloaded mitochondria","volume":"16","author":"Rodrigues","year":"2011","journal-title":"Redox Report"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib32","series-title":"Role of natural polysaccharides in the management of lifestyle diseases","first-page":"415","author":"Sar","year":"2023"},{"issue":"17","key":"10.1016\/B978-0-443-28942-2.00006-5_bib34","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.3390\/molecules28176379","article-title":"In silico modeling and structural analysis of soluble epoxide hydrolase inhibitors for enhanced therapeutic design","volume":"28","author":"Sar","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib35","doi-asserted-by":"crossref","first-page":"175588","DOI":"10.1016\/j.ejphar.2023.175588","article-title":"Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer","volume":"944","author":"Sarkar","year":"2023","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib36","series-title":"Therapeutic insights into herbal medicine through the use of phytomolecules","first-page":"228","article-title":"Citrus and its fight against cancer","author":"Sarkar","year":"2024"},{"issue":"2","key":"10.1016\/B978-0-443-28942-2.00006-5_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbrc.2015.06.031","article-title":"The mitochondrial phosphate carrier: Role in oxidative metabolism, calcium handling and mitochondrial disease","volume":"464","author":"Seifert","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib9052","doi-asserted-by":"crossref","DOI":"10.1177\/20417314211027677","article-title":"Current standards and ethical landscape of engineered tissues\u20143D bioprinting perspective","volume":"12","author":"Sekar","year":"2021","journal-title":"Journal of Tissue Engineering"},{"issue":"06\u201307","key":"10.1016\/B978-0-443-28942-2.00006-5_bib33","first-page":"306","article-title":"Monotherapy or combination therapy of oleanolic acid? From therapeutic significance and drug delivery to clinical studies: A comprehensive review","volume":"91","author":"Shaharyar","year":"2025","journal-title":"Planta Medica"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib38","doi-asserted-by":"crossref","first-page":"1221365","DOI":"10.3389\/fbioe.2023.1221365","article-title":"Recent developments in nanomaterials for upgrading treatment of orthopedics diseases","volume":"11","author":"Shang","year":"2023","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"1","key":"10.1016\/B978-0-443-28942-2.00006-5_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mito.2011.04.001","article-title":"VDAC, a multi-functional mitochondrial protein as a pharmacological target","volume":"12","author":"Shoshan-Barmatz","year":"2012","journal-title":"Mitochondrion"},{"issue":"11","key":"10.1016\/B978-0-443-28942-2.00006-5_bib40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3390\/pharmaceutics14112425","article-title":"Protein and gene delivery systems for neurodegenerative disorders: Where do we stand today?","volume":"14","author":"Siafaka","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/B978-0-443-28942-2.00006-5_bib41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/1535370216649445","article-title":"Programmable biomaterials for dynamic and responsive drug delivery","volume":"241","author":"Stejskalov\u00e1","year":"2016","journal-title":"Experimental Biology and Medicine"},{"issue":"6","key":"10.1016\/B978-0-443-28942-2.00006-5_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Current Opinion in HIV and AIDS"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib9053","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.612659","article-title":"Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards In Vitro Models and Adverse Outcome Pathways","volume":"12","author":"Tirumala","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/B978-0-443-28942-2.00006-5_bib43","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/nano13071247","article-title":"Nanotechnology-based diagnostics for diseases prevalent in developing countries: Current advances in point-of-care tests","volume":"13","author":"Thwala","year":"2023","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/B978-0-443-28942-2.00006-5_bib45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3311\/PPch.22826","article-title":"Nanoformulation of therapeutic enzymes: A short review","volume":"67","author":"T\u00f3th","year":"2023","journal-title":"Periodica Polytechnica Chemical Engineering"},{"key":"10.1016\/B978-0-443-28942-2.00006-5_bib44","doi-asserted-by":"crossref","first-page":"100416","DOI":"10.1016\/j.impact.2022.100416","article-title":"Analytical and toxicological aspects of nanomaterials in different product groups: Challenges and opportunities","volume":"28","author":"Tschiche","year":"2022","journal-title":"NanoImpact"},{"issue":"1","key":"10.1016\/B978-0-443-28942-2.00006-5_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12951-024-02478-5","article-title":"Nanozyme as a rising star for metabolic disease management","volume":"22","author":"Wang","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/B978-0-443-28942-2.00006-5_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2008.07.001","article-title":"Health effects related to nanoparticle exposures: Environmental, health and safety considerations for assessing hazards and risks","volume":"120","author":"Warheit","year":"2008","journal-title":"Pharmacology & Therapeutics"},{"issue":"3","key":"10.1016\/B978-0-443-28942-2.00006-5_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nano.2009.11.007","article-title":"Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease","volume":"6","author":"Yang","year":"2010","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"2","key":"10.1016\/B978-0-443-28942-2.00006-5_bib49","first-page":"139","article-title":"The mitochondrial permeability transition","volume":"1241","author":"Zoratti","year":"1995","journal-title":"BBA \u2013 Reviews on Biomembranes"}],"container-title":["Nanobiomaterials and Nanomedicines for Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443289422000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780443289422000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:32:51Z","timestamp":1763764371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780443289422000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443289422"],"references-count":53,"URL":"https:\/\/doi.org\/10.1016\/b978-0-443-28942-2.00006-5","relation":{},"subject":[],"published":{"date-parts":[[2026]]}}}